Results 231 to 240 of about 19,833 (262)

Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2021
Michael Anthonius Lim, Arief Wibowo, Henny Juliastuti   +2 more
exaly  

DPP-4 Inhibitors: Monotherapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

Expert Opinion on Drug Metabolism and Toxicology, 2016
André Scheen
exaly  

Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats

Archives of Medical Research, 2009
Tae Sun Park, Heung Yong Jin, Wei Jing Liu   +2 more
exaly  

Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor

Diabetes Research and Clinical Practice, 2015
Hisamitsu Ishihara, Masanori Abe, Suguru Yamaguchi   +2 more
exaly  

Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Postgraduate Medicine, 2011
Peter Tóth
exaly  

DPP-4 Inhibitors: An Overview

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

DPP-4 inhibitor

2014
HAYASHIDA OSAMU, KUSUBATA MASASHI, ATSUZAWA YUJI, TAGA YUKI, KOYAMA YOUICHI, HATTORI SHUNJI   +5 more
openaire   +2 more sources

Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report

Internal Medicine, 2012
Naoya Igaki
exaly  

A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats

Metabolism: Clinical and Experimental, 2016
Toshihide Yamasaki, Toyoshi Inoguchi, Noriyuki Sonoda   +2 more
exaly